A Tumor initiating cell-enriched prognostic signature for HER2(+):ERα(−) breast cancer; rationale, new features, controversies and future directions

The high intra- and inter-tumor heterogeneity of many types of cancers, including breast cancer (BC), poses great challenge to development of subtype-specific prognosis. In BC, the classification of tumors as either ERα(+) (Luminal A and Luminal B), HER2(+) (ERα(+) or ERα(−)) or triple-negative (TNB...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Liu, Jeff C., Egan, Sean E., Zacksenhaus, Eldad
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2013
Teme:
Research Perspective
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787160/
https://ncbi.nlm.nih.gov/pubmed/23945331
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki